Virta Health, a telehealth startup that helps people manage diabetes with frequent monitoring and dietary counseling, raises $65M, valuing the company at ~$1.1B
- Telehealth firm uses monitoring, counseling to optimize care — Series D round of $65 million brings equity to $231 million Thanks: @laurenwolk
Context & Ripple Effects
Virta Health's $65M Series D lands just months after Teladoc Health agreed to buy Livongo for $18.5B, the deal that put a headline price on connected chronic-disease management and signaled to investors that diabetes-focused telehealth can scale into an acquirable platform. Virta's approach — frequent monitoring plus dietary counseling rather than devices-first — now carries a ~$1.1B valuation on $231M of total equity raised.
The round sits inside a broader funding wave for virtual chronic care: Livongo itself raised $105M at an $800M+ valuation back in 2018 before its exit, and peers like Vida Health have since followed with large rounds of their own.
First-order effects
- Virta gains the capital to scale its diabetes-monitoring-and-counseling model toward the $2B valuation it would reach in its next round ($133M Series E), with employers and health plans as the buyer base this model targets.
- The ~$1.1B valuation makes Virta a unicorn while still private, giving it currency for hiring and payer contracts against device-led rivals.
Second-order effects
- Competing virtual-care startups are forced to raise at comparable scale to stay credible — Vida Health's $110M Series D led by General Atlantic, Centene, and AXA Venture Partners shows insurers themselves stepping in as backers of chronic-condition platforms.
- Teladoc's Livongo acquisition sets the M&A template: every funded diabetes-management startup now gets priced against that $18.5B benchmark, tightening the field between standalone growth and early exit.
Third-order effects
- Chronic-disease management is consolidating into a distinct telehealth category separate from general telemedicine visits, with dedicated unicorns (Virta, Cadence) and consumer-adjacent entrants like Levels' glucose-monitoring software competing for the same employer and payer budgets.
- If payer-backed rounds keep recurring, health plans shift from reimbursing virtual chronic care to owning stakes in the platforms that deliver it — blurring the line between buyer and vendor in digital health.
The trend: Telehealth capital is rotating from general-purpose visit platforms toward chronic-condition management, where monitoring-plus-coaching models are drawing unicorn valuations and insurer balance sheets.